Search

Your search keyword '"Valverde-Monge, Marcela"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Valverde-Monge, Marcela" Remove constraint Author: "Valverde-Monge, Marcela"
42 results on '"Valverde-Monge, Marcela"'

Search Results

1. Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

2. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

3. Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers

4. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

5. Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation

7. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection

8. Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities

10. Safety and efficacy of benralizumab in elderly subjects with severe asthma.

11. COMPARISON OF LONG-TERM RESPONSE AND REMISSION TO OMALIZUMAB AND ANTI-IL5/IL5R USING DIFFERENT CRITERIA IN A REAL-LIFE COHORT OF SEVERE ASTHMA PATIENTS

12. The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort

13. The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria

14. Obese Asthma Phenotype Is Associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p Modulating the IGF Axis

15. EAACI Molecular Allergology User's Guide 2.0

16. EAACI Molecular Allergology User's Guide 2.0

17. EAACI Molecular Allergology User's Guide 2.0

19. Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids

20. Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids

22. How reliably can algorithms identify eosinophilic asthma phenotypes using non‐invasive biomarkers?

23. Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort

24. Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study

26. Reply to "European academy of allergy and clinical immunology, food allergy, anaphylaxis guidelines group. EAACI guidelines: Anaphylaxis (2021 update)".

28. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients

31. Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma

32. Novel causes of drug-induced occupational asthma

36. Allergy to Pumpkin Seeds

38. Novel causes of drug-induced occupational asthma

39. Single‐cell RNA sequencing of human blood eosinophils reveals plasticity and absence of canonical cell subsets.

40. Anxiety and BMI affect asthma control: data from a prospective Spanish cohort

41. Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics.

42. The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.

Catalog

Books, media, physical & digital resources